A carregar...
Inhibition of Primary Clinical Isolates of Human Parainfluenza Virus by DAS181 in Cell Culture and in a Cotton Rat Model
DAS181 is a novel drug in development for the treatment of influenza as well as human parainfluenza viruses (hPIV). Previous studies demonstrated that DAS181 inhibited laboratory strains of hPIV, but no tests were conducted with primary clinical isolates of hPIV. To fill this gap, we studied six pri...
Na minha lista:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3871174/ https://ncbi.nlm.nih.gov/pubmed/24076357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2013.09.014 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|